Enhancing prime editing in hematopoietic stem and progenitor cells by modulating nucleotide metabolism
- PMID: 38806736
- DOI: 10.1038/s41587-024-02266-4
Enhancing prime editing in hematopoietic stem and progenitor cells by modulating nucleotide metabolism
Abstract
Therapeutic prime editing of hematopoietic stem and progenitor cells (HSPCs) holds great potential to remedy blood disorders. Quiescent cells have low nucleotide levels and resist retroviral infection, and it is possible that nucleotide metabolism could limit reverse transcription-mediated prime editing in HSPCs. We demonstrate that deoxynucleoside supplementation and Vpx-mediated degradation of SAMHD1 improve prime editing efficiency in HSPCs, especially when coupled with editing approaches that evade mismatch repair.
© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.
Conflict of interest statement
Competing interests: S.L. and D.E.B. have filed a provisional patent application related to this work. All other authors have no competing interests.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
